Published in
Springer, Cancer Chemotherapy and Pharmacology, 3(82), p. 407-418, 2018
DOI: 10.1007/s00280-018-3623-7
Links
Tools
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Journal article published in 2018 by
Amita Patnaik,
Michael Gordon,
Frank Tsai,
Kyri Papadopoulous 
,
Drew Rasco,
S. Muralidhar Beeram,
Siqing Fu ,
Filip Janku ,
Scott M. Hynes,
Sushma R. Gundala ,
Melinda D. Willard,
Wei Zhang,
Aimee Bence Lin,
David Hong
,
Drew Rasco,
S. Muralidhar Beeram,
Siqing Fu ,
Filip Janku ,
Scott M. Hynes,
Sushma R. Gundala ,
Melinda D. Willard,
Wei Zhang,
Aimee Bence Lin,
David Hong
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 